Here are five things to know:
1. This device is the first PMMA to receive clearance for the fixation of pathological sacral fractures using sacral vertebroplasty or sacroplasty.
2. Stryker released its VertaPlex HV in 2008, which offered viscosity and working time preferences for vertebral compression fracture treatments.
3. Sacral vertebroplasty injects bone cement into the sacrum in hopes of reducing pain and allowing mobilization.
4. Diagnosing sacral insufficiency fractures proves challenging because lumbar spine imaging does not target the sacrum.
5. Cement extravasation is a possible complication with the procedure, so high viscosity cement helps limit cement spreading.
“As our population ages, we will see more sacral insufficiency fractures that will require intervention,” said Douglas Yim, MD, visiting associate professor, associate program director of interventional radiology, Johns Hopkins Schools of Medicine. “Having a reliable and consistent high viscosity cement like VertaPlex HV will allow greater margin of safety for patients undergoing sacroplasty.”
More articles on devices:
SeaSpine launches interbody device: 5 key notes
LDR, NuVasive, Spine Wave & more — 23 key notes
IlluminOss Medical names Manny Avila CEO: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
